Johnson & Johnson Gets Punitive Damages in Risperdal Case Reduced to $6.8 Million

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jan 18, 2020 at 12:02 AM.

  1. #1 cafead, Jan 18, 2020 at 12:02 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,057
    Likes Received:
    3
    via Healthcare giant Johnson & Johnson (NYSE: JNJ) got good news on Friday when a Philadelphia judge drastically reduced the $8 billion punitive damage verdict the company was initially ordered to pay in October down to just $6.8 million.

    article source
     
    Quote

Reply to Thread